UnitedHealth Group said its motion to dismiss the DOJ lawsuit was moot after the agency cited which regions would be impacted ...

Some believe that the previous Trump administration was more favorable to large corporations, likely making blocking the UHG/Amedisys deal less of a priority, compared with the Biden ...

UnitedHealth Group Inc. (NYSE: UNH) is dropping its motion to dismiss the U.S. Department of Justice’s (DOJ) antitrust lawsuit regarding the company’s ...

BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...

Amedisys stock climbed Friday after the provider ... also provides UNH the abilityto engage with the DOJ under the new administration for a potential remedy,” the analysts said.

Amedisys, Inc. (NASDAQ:AMED – Free Report) – Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for Amedisys in a note issued to investors on Wednesday, January 29th.

In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price target of $101.00. Whit Mayo has given his Hold ...